{"id":"https://openalex.org/W2014407178","doi":"https://doi.org/10.1007/s40263-013-0100-z","title":"Modelling the Risk of Visual Field Loss Arising from Long-Term Exposure to the Antiepileptic Drug Vigabatrin: A Cross-Sectional Approach","display_name":"Modelling the Risk of Visual Field Loss Arising from Long-Term Exposure to the Antiepileptic Drug Vigabatrin: A Cross-Sectional Approach","publication_year":2013,"publication_date":"2013-08-29","ids":{"openalex":"https://openalex.org/W2014407178","doi":"https://doi.org/10.1007/s40263-013-0100-z","mag":"2014407178","pmid":"https://pubmed.ncbi.nlm.nih.gov/23990316"},"language":"en","primary_location":{"id":"doi:10.1007/s40263-013-0100-z","doi":"https://doi.org/10.1007/s40263-013-0100-z","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40263-013-0100-z","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024606893","display_name":"John M. Wild","orcid":"https://orcid.org/0000-0003-3019-3889","observed_orcids":["https://orcid.org/0000-0003-3019-3889"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"John M. Wild","raw_affiliation_strings":["Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Maindy Road, Cardiff, Wales, CF24 4HQ, UK, wildjm@cardiff.ac.uk","Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Maindy Road, Cardiff, Wales, CF24 4HQ, UK, wildjm@cardiff.ac.uk","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053211657","display_name":"David L. Fone","orcid":"https://orcid.org/0000-0002-6476-4881","observed_orcids":["https://orcid.org/0000-0002-6476-4881"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David L. Fone","raw_affiliation_strings":["Cochrane Institute of Primary Care and Public Health, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff, Wales, CF14 4YS, UK","Cochrane Institute of Primary Care and Public Health, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cochrane Institute of Primary Care and Public Health, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff, Wales, CF14 4YS, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Cochrane Institute of Primary Care and Public Health, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071615097","display_name":"Saleh Aljarudi","orcid":"https://orcid.org/0000-0003-2251-7206","observed_orcids":["https://orcid.org/0000-0003-2251-7206"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Saleh Aljarudi","raw_affiliation_strings":["Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Maindy Road, Cardiff, Wales, CF24 4HQ, UK","Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Maindy Road, Cardiff, Wales, CF24 4HQ, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Cardiff Centre for Vision Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082059814","display_name":"Charlotte Lawthom","orcid":"https://orcid.org/0000-0003-1774-6506","observed_orcids":["https://orcid.org/0000-0003-1774-6506"]},"institutions":[{"id":"https://openalex.org/I2800476137","display_name":"Royal Gwent Hospital","ror":"https://ror.org/03vt5c527","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800476137","https://openalex.org/I2802109268","https://openalex.org/I4210144625"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Lawthom","raw_affiliation_strings":["Department of Neurology, Royal Gwent Hospital, Cardiff Road, Newport, Wales, NP20 2UB, UK","Department of Neurology Royal Gwent Hospital  Newport UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Royal Gwent Hospital, Cardiff Road, Newport, Wales, NP20 2UB, UK","institution_ids":["https://openalex.org/I2800476137"]},{"raw_affiliation_string":"Department of Neurology Royal Gwent Hospital  Newport UK","institution_ids":["https://openalex.org/I2800476137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102775077","display_name":"Phil E M Smith","orcid":"https://orcid.org/0000-0003-4250-2562","observed_orcids":["https://orcid.org/0000-0003-4250-2562"]},"institutions":[{"id":"https://openalex.org/I2800861664","display_name":"University Hospital of Wales","ror":"https://ror.org/04fgpet95","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1299209451","https://openalex.org/I2800861664","https://openalex.org/I4210144625"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Philip E. M. Smith","raw_affiliation_strings":["The Alan Richens Unit, Welsh Epilepsy Centre, University Hospital of Wales, Heath Park, Cardiff, Wales, CF14 4XW, UK","The Alan Richens Unit, Welsh Epilepsy Centre, University Hospital of Wales, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Alan Richens Unit, Welsh Epilepsy Centre, University Hospital of Wales, Heath Park, Cardiff, Wales, CF14 4XW, UK","institution_ids":["https://openalex.org/I2800861664"]},{"raw_affiliation_string":"The Alan Richens Unit, Welsh Epilepsy Centre, University Hospital of Wales, Cardiff, UK","institution_ids":["https://openalex.org/I2800861664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064669357","display_name":"Robert Gordon Newcombe","orcid":"https://orcid.org/0000-0003-4400-8867","observed_orcids":["https://orcid.org/0000-0003-4400-8867"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert G. Newcombe","raw_affiliation_strings":["Cochrane Institute of Primary Care and Public Health, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff, Wales, CF14 4YS, UK","Cochrane Institute of Primary Care and Public Health, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cochrane Institute of Primary Care and Public Health, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Heath Park, Cardiff, Wales, CF14 4YS, UK","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Cochrane Institute of Primary Care and Public Health, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"last","author":{"id":null,"display_name":"Gareth D. Lewis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800861664","display_name":"University Hospital of Wales","ror":"https://ror.org/04fgpet95","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1299209451","https://openalex.org/I2800861664","https://openalex.org/I4210144625"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gareth D. Lewis","raw_affiliation_strings":["Cardiff Eye Unit, University Hospital of Wales, Heath Park, Cardiff, Wales, CF14 4XW, UK","Cardiff Eye Unit University Hospital of Wales Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff Eye Unit, University Hospital of Wales, Heath Park, Cardiff, Wales, CF14 4XW, UK","institution_ids":["https://openalex.org/I2800861664"]},{"raw_affiliation_string":"Cardiff Eye Unit University Hospital of Wales Cardiff, UK","institution_ids":["https://openalex.org/I2800861664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5024606893"],"corresponding_institution_ids":["https://openalex.org/I79510175"],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":null,"fwci":0.5628,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.66854524,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"27","issue":"10","first_page":"841","last_page":"849"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.16910000145435333,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.02630000002682209,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.9850000143051147},{"id":"https://openalex.org/keywords/visual-field-defects","display_name":"visual field defects","score":0.9860000014305115},{"id":"https://openalex.org/keywords/antiepileptic-drug-side-effects","display_name":"antiepileptic drug adverse effects","score":0.7910000085830688},{"id":"https://openalex.org/keywords/long-term-drug-exposure","display_name":"long-term drug exposure","score":0.8090000152587891},{"id":"https://openalex.org/keywords/cumulative-dose","display_name":"cumulative dose","score":0.8180000185966492},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.8569999933242798},{"id":"https://openalex.org/keywords/risk-modeling","display_name":"risk modeling","score":0.5649999976158142},{"id":"https://openalex.org/keywords/visual-field-perimetry","display_name":"visual field perimetry","score":0.7369999885559082},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.531000018119812},{"id":"https://openalex.org/keywords/epilepsy-clinic-patients","display_name":"epilepsy clinic patients","score":0.4959999918937683},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.6150000095367432},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.31299999356269836},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.3199999928474426}],"concepts":[{"id":"https://openalex.org/C2780837902","wikidata":"https://www.wikidata.org/wiki/Q421663","display_name":"Vigabatrin","level":4,"score":0.9779136180877686},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7616432905197144},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.746403157711029},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6399105787277222},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5297958254814148},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5294121503829956},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5066109895706177},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.42919689416885376},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34704381227493286},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2947251796722412},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.2565532326698303},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1914549171924591},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.059889256954193115}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014794","descriptor_name":"Visual Fields","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D058609","descriptor_name":"Visual Field Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s40263-013-0100-z","doi":"https://doi.org/10.1007/s40263-013-0100-z","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40263-013-0100-z","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},{"id":"pmid:23990316","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23990316","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS drugs","raw_type":"Journal Article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:51653","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/51653/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320337846","display_name":"UCB Pharma","ror":"https://ror.org/01n029866"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W101328159","https://openalex.org/W1542887848","https://openalex.org/W1607402462","https://openalex.org/W1948601338","https://openalex.org/W1964026305","https://openalex.org/W1969873798","https://openalex.org/W1985422482","https://openalex.org/W1986159818","https://openalex.org/W1988302543","https://openalex.org/W2000344229","https://openalex.org/W2000997080","https://openalex.org/W2002141786","https://openalex.org/W2012509866","https://openalex.org/W2016499969","https://openalex.org/W2021547803","https://openalex.org/W2025951716","https://openalex.org/W2028335319","https://openalex.org/W2031723474","https://openalex.org/W2035320756","https://openalex.org/W2038749218","https://openalex.org/W2049214932","https://openalex.org/W2050219242","https://openalex.org/W2056049122","https://openalex.org/W2056539787","https://openalex.org/W2059167774","https://openalex.org/W2069995172","https://openalex.org/W2070403944","https://openalex.org/W2077616658","https://openalex.org/W2080221650","https://openalex.org/W2083563713","https://openalex.org/W2084737169","https://openalex.org/W2085048192","https://openalex.org/W2085050047","https://openalex.org/W2088030006","https://openalex.org/W2095185628","https://openalex.org/W2114390763","https://openalex.org/W2115647035","https://openalex.org/W2116602570","https://openalex.org/W2122633654","https://openalex.org/W2128630347","https://openalex.org/W2149094349","https://openalex.org/W2159399505","https://openalex.org/W2162594619","https://openalex.org/W2163662781","https://openalex.org/W4238087098"],"related_works":["https://openalex.org/W1974267703","https://openalex.org/W1948601338","https://openalex.org/W1607402462","https://openalex.org/W2138475110","https://openalex.org/W2115647035","https://openalex.org/W2955749966","https://openalex.org/W2069565378","https://openalex.org/W2049214932","https://openalex.org/W2062502520","https://openalex.org/W2016655873"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}